Top

Published in:

01-12-2019 | Benzodiazepine | Concise Research Reports

Benzodiazepine Use in the USA Is Driven by Long-term Users: a Repeated Cross-sectional Study of MEPS 2002–2016

Authors: Michael E. Johansen, MD, MS, Joshua D. Niforatos, MTS

Published in: Journal of General Internal Medicine | Issue 12/2019

Excerpt

Benzodiazepines can be an effective short-term adjunct for psychiatric conditions managed in the outpatient setting.¹ Recent studies on benzodiazepine prescribing reveal increases in concurrent opioid prescribing² and prescribing in the ambulatory setting.³ Other reports document increase overdose mortality from benzodiazepines over the past decade secondary to concurrent opioid use.⁴ Despite this, less is known about how individuals use benzodiazepines over time. Without knowing how individuals use this medication, the abovementioned measures may overestimate benzodiazepine use. We thus sought to describe benzodiazepine use among the adult population using longitudinal cohort data. …

Locke AB, Kirst N, Shultz C. Diagnosis and management of generalized anxiety disorder and panic disorder in adults. Am Fam Physician. 2015;91:617–24.PubMed

Ladapo JA, Larochelle MR, Chen A, et al. Physician prescribing of opioids to patients at increased risk of overdose from benzodiazepine use in the United States. JAMA Psychiatry. 2018;75:623–630.CrossRef

Agarwal SD, Landon BE. Patterns in outpatient benzodiazepine prescribing in the United States. JAMA Netw Open. 2019;2:e187399.CrossRef

National Institutes of Health, National Institute on Drug Abuse. Overdose Death Rates. Revised January 2019. Available at https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates. Accessed April 4, 2019.

Agency for Healthcare Research and Quality (AHRQ). Center for Financing, Access, and Cost Trends MEPS HC-181: 2016 Full Year Consolidated Data File. https://meps.ahrq.gov/data_stats/download_data/pufs/h192/h192doc.pdf. Published August 2018. Accessed January 2019.

Kroll DS, Nieva HR, Barsky AJ, Linder JA. Benzodiazepines are prescribed more frequently to patients already at risk for benzodiazepine-related adverse events in primary care. J Gen Int Med. 2016;31:1027–1034.CrossRef

Title: Benzodiazepine Use in the USA Is Driven by Long-term Users: a Repeated Cross-sectional Study of MEPS 2002–2016
Authors: Michael E. Johansen, MD, MS
Joshua D. Niforatos, MTS
Publication date: 01-12-2019
Publisher: Springer US
Keyword: Benzodiazepine
Published in: Journal of General Internal Medicine / Issue 12/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-019-05042-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Benzodiazepine Use in the USA Is Driven by Long-term Users: a Repeated Cross-sectional Study of MEPS 2002–2016

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2019

Pharmacotherapy for Cocaine Use Disorder—a Systematic Review and Meta-analysis

Electronic Health Record Phenotypes for Identifying Patients with Late-Stage Disease: a Method for Research and Clinical Application

Expert Recommendations on Frequency of Utilization of Common Laboratory Tests in Medical Inpatients: a Canadian Consensus Study

Impact of Project ECHO Models of Medical Tele-Education: a Systematic Review

Improving Care for Patients with Sickle Cell Disease: a Qualitative Study of Hospitalized Sickle Cell Patients

Racial and Ethnic Differences in Healthcare Utilization among Medicare Fee-For-Service Enrollees

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page